(Q33922539)

English

Preliminary evaluation of a highly automated instrument for the selection of CD34+ cells from mobilized peripheral blood stem cell concentrates

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Preliminary evaluation of a highly automated instrument for the selection of CD34+ cells from mobilized peripheral blood stem cell concentrates (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Virginia Sheikh

7

object named as

Virginia Sheikh

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

8

object named as

Irini Sereti

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

David F Stroncek

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Minh Tran

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sue Ellen Frodigh

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Virginia David-Ocampo

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jiaqiang Ren

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Andre Larochelle

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jeffery L Miller

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Kevin Longin

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Marianna Sabatino

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

511-517

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5521017

5 July 2018

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5521017

5 July 2018

Gene therapy through autologous transplantation of gene-modified hematopoietic stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5521017

5 July 2018

Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5521017

5 July 2018

Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5521017

5 July 2018

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5521017

5 July 2018

Allogeneic natural killer cells for refractory lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5521017

5 July 2018

Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13394

21 January 2018

Immunomagnetic cell selection performed for HLA haploidentical transplants with the CliniMACS device: effect of additional platelet removal on CD34+ cell recovery.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13394

21 January 2018

Automated CD34+ cell isolation of peripheral blood stem cell apheresis product

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13394

21 January 2018

HLA-matched sibling transplantation with BM and CD34(+)-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13394

21 January 2018

Haploidentical related-donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34(+) cells and a fixed CD3(+) dose

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13394

21 January 2018

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5521017

29 October 2018

Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back

1 reference

https://pubmed.ncbi.nlm.nih.gov/26505619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26505619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD34 selected alloPBSCT and adoptive immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26505619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device

1 reference

https://pubmed.ncbi.nlm.nih.gov/26505619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive immunomagnetic CD34(+) cell selection in haplo-identical transplants in beta-thalassemia patients: removal of platelets using an automated system

1 reference

https://pubmed.ncbi.nlm.nih.gov/26505619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/TRF.13394

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33922539&oldid=2046723290"